Search / Trial NCT06224153

Assessment of Protein Intake Using 2 Types of Nutritional Collection in Chronic Kidney Disease.

Launched by ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE · Jan 16, 2024

Trial Information

Current as of December 22, 2024

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how well two different methods for tracking protein intake work for patients with chronic kidney disease (CKD) stages 4 and 5. The goal is to see if a new web application, which collects dietary information through a food frequency questionnaire (FFQ), can accurately assess protein consumption compared to traditional methods like a 3-day dietary record and a 24-hour urine test. A low-protein diet may help delay the need for dialysis, so understanding protein intake is very important for managing CKD.

To be eligible for the trial, participants must be at least 18 years old, able to understand the study, and motivated to try a low-protein diet. They also need to be diagnosed with CKD stages 4 or 5 and have access to a computer or smartphone. During the study, participants will use the web application to report their food intake, and their results will be compared to the other assessment methods. This research aims to provide better tools for dietitians to help manage kidney disease effectively.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient at least 18 years of age,
  • Patient capable of understanding the study and having given informed non-opposition,
  • Patient with stage 4 or 5 CKD,
  • Patient included in the MRC pathway,
  • Patient motivated by a hypo-protein diet,
  • Patient able to use a computer/smartphone/tablet with Internet access.
  • Exclusion Criteria:
  • Difficulty reading or understanding the French language,
  • Patient with ongoing cancer,
  • Patient undernourished or at risk of undernutrition (based on weight loss and albumin measurement from last blood test),
  • Persons covered by articles L. 1121-5 to L. 1121-8 of the French Public Health Code (minors, adults under guardianship or trusteeship, patients deprived of their liberty, pregnant or breast-feeding women).
  • Dialysis patient
  • Patient who underwent major surgery less than 3 months ago.

Trial Officials

François CREMIEUX

Study Director

AP-HM

About Assistance Publique Hopitaux De Marseille

Assistance Publique - Hôpitaux de Marseille (AP-HM) is a leading public healthcare institution in France, dedicated to providing high-quality medical care and advancing research in various clinical fields. As a prominent sponsor of clinical trials, AP-HM is committed to fostering innovation and improving patient outcomes through rigorous scientific investigation. With a multidisciplinary approach, the institution collaborates with a network of healthcare professionals, researchers, and academic partners to facilitate cutting-edge studies that address critical health challenges. AP-HM's dedication to ethical standards and patient safety underscores its role as a trusted leader in clinical research and healthcare delivery.

Locations

Marseille, , France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0